stockrowXtant Medical Holdings, Inc.
XTNTXtant Medical Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $133.9 million, up 14.2% from fiscal 2024.
- Revenue
- −35.0%
- EPS
- −333.3%
- Free cash flow
- −882.0%
- Total debt
- −33.0%
Quarter to June 2026, against a year earlier
Follow XTNT
Alert me
Xtant Medical Holdings, Inc. (XTNT) Return on invested capital
Xtant Medical Holdings, Inc.'s return on invested capital over the twelve months to 30 June 2026 was −12.4%, down 20.1 percentage points from fiscal 2025 (7.71%). Over the past ten years it has ranged from −134.1% (fiscal 2018) to 7.71% (fiscal 2025) — the current reading is the highest in ten years. That is below the Medical Devices industry median of −7.11% and below the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 7.71% | 18.35 |
| FY2024 | −10.6% | (1.21) |
| FY2023 | −9.43% | 5.01 |
| FY2022 | −14.4% | (5.84) |
| FY2021 | −8.60% | (7.05) |
| FY2020 | −1.55% | 3.59 |
| FY2019 | −5.14% | 128.96 |
| FY2018 | −134.1% | (103.55) |
| FY2017 | −30.6% | (26.65) |
| FY2016 | −3.90% | 2.77 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| NSYS Nortech Systems Incorporated compare | 5.68% |
| ELUT Elutia Inc. compare | 0.00% |
| MDAI Spectral AI, Inc. compare | 0.00% |
| XTNT Xtant Medical Holdings, Inc. | −12.4% |
| QTI QT Imaging Holdings, Inc. compare | −48.3% |
| MYO Myomo, Inc. compare | −145.8% |
| RPID Rapid Micro Biosystems, Inc. compare | −181.6% |
| TELA TELA Bio, Inc. compare | −232.8% |
| NSPR InspireMD, Inc. compare | −3,071.0% |
| Medical Devices industry median | −7.11% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)